| abstract |
The present invention provides methods for inhibiting bone loss comprising administering to a mammal in need of treatment of a bone loss inhibiting amount of a compound of formula I ##STR1## wherein R is hydrogen or methyl; n R 1 and R 2 each are methyl or ethyl, or R 1 and R 2 together with the nitrogen atom to which they are attached represent a saturated heterocyclic group; and n X is bromo, chloro, fluoro, or hydrogen; or a pharmaceutically acceptable salt thereof. |